An efficient constitutive expression system for Anti-CEACAM5 nanobody production in the yeast Pichia pastoris.
Animals
Batch Cell Culture Techniques
Camelids, New World
Carcinoembryonic Antigen
/ immunology
GPI-Linked Proteins
/ immunology
Gene Expression
Genetic Vectors
/ genetics
Glyceraldehyde-3-Phosphate Dehydrogenases
/ genetics
Humans
Pichia
/ genetics
Promoter Regions, Genetic
Recombinant Proteins
/ genetics
Single-Domain Antibodies
/ genetics
Anti-CEACAM5
Constitutive expression
GAP promoter
Nanobody
Pichia pastoris
Journal
Protein expression and purification
ISSN: 1096-0279
Titre abrégé: Protein Expr Purif
Pays: United States
ID NLM: 9101496
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
10
10
2018
accepted:
05
11
2018
pubmed:
12
11
2018
medline:
13
3
2020
entrez:
12
11
2018
Statut:
ppublish
Résumé
Nanobodies offer multiple advantages over conventional antibodies in terms of size, stability, solubility, immunogenicity, and production costs, with improved tumor uptake and blood clearance. Additionally, the recombinant expression of nanobodies is robust in various expression systems, such as Escherichia coli, Saccharomyces cerevisiae and Pichia pastoris. P. pastoris is the most widely used microorganism for nanobody production, but all or almost all expression vectors developed for this system are based on the regulated promoter of the alcohol oxidase 1 gene (AOX1) that requires methanol for full induction. In this study, a constitutive anti-CEACAM5 nanobody expression system was constructed under the control of a glyceraldehyde-3-phosphate dehydrogenase promoter (GAP) promoter. The effects of different carbon sources and pH on nanobody expression were evaluated in shaking flask cultures. After 96 h of constitutive expression in shaking flask, a yield of 51.71 mg/L was obtained. In addition, this constitutive expression system produced nanobodies at equivalent yield and affinity to that produced by methanol-induced expression. The results of this study indicated that the use of a constitutive expression system is a promising alternative for the production of nanobodies applied for cancer diagnosis and therapy.
Identifiants
pubmed: 30414968
pii: S1046-5928(18)30525-4
doi: 10.1016/j.pep.2018.11.001
pii:
doi:
Substances chimiques
CEACAM5 protein, human
0
Carcinoembryonic Antigen
0
GPI-Linked Proteins
0
Recombinant Proteins
0
Single-Domain Antibodies
0
Glyceraldehyde-3-Phosphate Dehydrogenases
EC 1.2.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
43-47Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.